Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

Antibody treatments show promise for hair loss but need more research.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Finasteride helps female-pattern hair loss.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

Finasteride improves hair growth in men with androgenetic alopecia.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Treatment during development affects hormone balance and sexual behavior in male rats.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Herbal formula shows promise for hair loss treatment.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Finasteride may improve prostate cancer treatment outcomes.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Dutasteride and finasteride affect different cell types differently.